WebDalton Transactions is a journal for all areas of inorganic chemistry, which encompasses the organometallic, bioinorganic and materials chemistry of the elements, with applications including synthesis, catalysis, energy conversion/storage, electrical devices and medicine. Dalton Transactions welcomes high-quality, original submissions in all of ... WebBiochemical Society Transactions publishes concise reviews from across biochemistry and molecular biology. Papers are written by experts in the field, providing a timely …
Bioscience Journal Abbreviations: Abbreviations A - B
WebImpact Factor: 4.919. ... Biochemical Society Transactions publishes original academic documents which undergo peer review by experts in the given subject area. The journal welcomes submissions from the research community where attention will be on the novelty and the practical impact of the reported research. Biochemical Society Transactions ... WebBiochemical Society Transactions. Impact Factor History. 2024/2024 Impact Factor 5.407; 2024 Impact Factor 4.291; 2024 Impact Factor 4.316; 2024 Impact Factor 3.561; 2016 Impact Factor 3.016; 2015 Impact Factor 3.094; 2014 Impact Factor 3.546; 2013 Impact Factor 3.630; 2012 Impact Factor 3.116; 2011 Impact Factor 4.133; 2010 … jarray get value by key c#
Biochimie Journal ScienceDirect.com by Elsevier
WebThe general transcription factor TFIIB (transcription factor IIB) plays a critical role in the assembly of the RNA polymerase II pre-initiation complex. TFIIB can make sequence-specific DNA contacts both upstream and downstream of the TATA box. ... Biochem Soc Trans. 2006 Dec;34(Pt 6):1051-3. doi: 10.1042/BST0341051. Authors W Deng 1 , S G E ... WebBiochem Soc Trans. 2009 Dec;37(Pt 6):1237-42. doi ... is a new risk factor for cardiovascular disease. No therapies exist to prevent or treat this condition, even to achieve a modest improvement in pregnancy length or birth weight. ... even a modest prolongation of pregnancy or amelioration of the condition could have a significant beneficial ... WebASSAY and Drug Development Technologies. Editor-in-Chief: Bruce J. Melancon, PhD. ISSN: 1540-658X Online ISSN: 1557-8127 8 Issues AnnuallyCurrent Volume: 21. Impact Factor: 2.471* *2024 Journal Citation Reports™ (Clarivate, 2024) low hanging fruit jokes